loading
前日終値:
$37.98
開ける:
$38.04
24時間の取引高:
186.99K
Relative Volume:
0.79
時価総額:
$1.58B
収益:
$1.50B
当期純損益:
$95.23M
株価収益率:
16.68
EPS:
2.328
ネットキャッシュフロー:
$12.77M
1週間 パフォーマンス:
+1.36%
1か月 パフォーマンス:
+9.97%
6か月 パフォーマンス:
-27.95%
1年 パフォーマンス:
+0.65%
1日の値動き範囲:
Value
$37.24
$38.94
1週間の範囲:
Value
$36.53
$39.64
52週間の値動き範囲:
Value
$28.25
$60.08

Phibro Animal Health Corp Stock (PAHC) Company Profile

Name
名前
Phibro Animal Health Corp
Name
セクター
Healthcare (1052)
Name
電話
201-329-7300
Name
住所
GLENPOINTE CENTRE EAST, 3RD FLOOR, TEANECK, NJ
Name
職員
2,605
Name
Twitter
@phibroeurope
Name
次回の収益日
2026-11-04
Name
最新のSEC提出書
Name
PAHC's Discussions on Twitter

Compare PAHC vs TAK, TEVA, HLN, ZTS, UTHR

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
PAHC icon
PAHC
Phibro Animal Health Corp
38.82 1.58B 1.50B 95.23M 12.77M 2.328
TAK icon
TAK
Takeda Pharmaceutical Co Adr
19.67 62.84B 29.91B 1.30B 3.49B 0.4056
TEVA icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
41.50 48.40B 17.53B 1.58B 444.18M 1.3457
HLN icon
HLN
Haleon Plc Adr
10.13 44.55B 14.54B 2.22B 2.58B 0.4871
ZTS icon
ZTS
Zoetis Inc
79.38 32.80B 9.51B 2.64B 2.14B 6.0361
UTHR icon
UTHR
United Therapeutics Corp
533.12 22.87B 3.17B 1.29B 1.01B 27.09

Phibro Animal Health Corp Stock (PAHC) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-04-15 開始されました Citigroup Neutral
2025-07-07 アップグレード JP Morgan Neutral → Overweight
2025-06-16 アップグレード BNP Paribas Exane Underperform → Neutral
2024-09-10 開始されました JP Morgan Neutral
2023-12-07 開始されました Exane BNP Paribas Underperform
2022-12-21 開始されました ROTH Capital Buy
2022-07-25 ダウングレード Barclays Equal Weight → Underweight
2022-01-10 アップグレード Barclays Underweight → Equal Weight
2021-11-18 開始されました Morgan Stanley Equal-Weight
2021-08-05 再開されました Credit Suisse Neutral
2021-07-07 ダウングレード Barclays Equal Weight → Underweight
2020-08-06 ダウングレード Morgan Stanley Equal-Weight → Underweight
2020-02-06 ダウングレード Gabelli & Co Buy → Hold
2020-01-28 アップグレード Barclays Underweight → Equal Weight
2019-09-05 アップグレード Morgan Stanley Underweight → Equal-Weight
2019-08-29 繰り返されました BofA/Merrill Underperform
2019-06-11 開始されました Barclays Underweight
2019-05-23 開始されました Guggenheim Neutral
2019-05-09 アップグレード Gabelli & Co Hold → Buy
2017-08-23 再開されました BofA/Merrill Underperform
2017-06-02 ダウングレード Credit Suisse Outperform → Neutral
2016-12-15 開始されました Piper Jaffray Overweight
2016-11-11 ダウングレード Macquarie Neutral → Underperform
2016-11-10 ダウングレード Gabelli & Co Buy → Hold
2016-04-11 繰り返されました Guggenheim Buy
2016-02-04 開始されました Credit Suisse Outperform
2016-01-15 ダウングレード Barclays Overweight → Underweight
2015-09-30 開始されました Gabelli & Co Buy
2015-04-24 繰り返されました Barclays Overweight
2015-04-21 ダウングレード Morgan Stanley Equal-Weight → Underweight
2014-05-06 開始されました Barclays Overweight
すべてを表示

Phibro Animal Health Corp (PAHC) 最新ニュース

pulisher
Oct 16, 2026

Reasons to Add STE Stock to Your Portfolio Right Now - Zacks Investment Research

Oct 16, 2026
pulisher
Oct 16, 2026

Haemonetics Gains 149.3% in a Year: What's Driving the Rally? - Zacks Investment Research

Oct 16, 2026
pulisher
Oct 16, 2026

Is it Apt to Retain Medtronic Stock in Your Portfolio Now? - Zacks Investment Research

Oct 16, 2026
pulisher
Oct 15, 2026

Is it Apt to Retain Prestige Consumer Stock in Your Portfolio Now? - Zacks Investment Research

Oct 15, 2026
pulisher
Oct 09, 2026

Is it the Right Time to Hold TNDM Stock in Your Portfolio? - Zacks Investment Research

Oct 09, 2026
pulisher
Oct 08, 2026

Is it the Right Time to Add Phibro Stock to Your Portfolio? - Zacks Investment Research

Oct 08, 2026
pulisher
Oct 07, 2026

Encompass Health Expands Rehab Footprint With New Maine Hospital - Zacks Investment Research

Oct 07, 2026
pulisher
Oct 07, 2026

Is This the Right Time to Add TMO Stock to Your Portfolio? - Zacks Investment Research

Oct 07, 2026
pulisher
Oct 01, 2026

Neogen Stock Rallies 83% YTD: What's Driving the Surge? - Zacks Investment Research

Oct 01, 2026
pulisher
Sep 30, 2026

Should You Continue to Hold IART Stock in Your Portfolio? - Zacks Investment Research

Sep 30, 2026
pulisher
Sep 29, 2026

Chewy's Vet Care Posts Triple-Digit Growth as Clinic Scale Builds - Zacks Investment Research

Sep 29, 2026
pulisher
Sep 29, 2026

Is This the Right Time to Add Labcorp Stock to Your Portfolio? - Zacks Investment Research

Sep 29, 2026
pulisher
Sep 25, 2026

Phibro Animal Health (NasdaqGM:PAHC) Stock Forecast & Analyst Predictions - Simply Wall Street

Sep 25, 2026
pulisher
Sep 18, 2026

Phibro Animal Health CFO David Glenn Granted 3,482 Shares, Increasing Holdings to 54,959 - Kalkine Media

Sep 18, 2026
pulisher
Sep 17, 2026

Phibro Animal Health (PAHC) updates CFO’s 3,482-unit stock grant - Stock Titan

Sep 17, 2026
pulisher
Sep 17, 2026

COO stock award takes Phibro Animal Health (PAHC) stake to 38,275 units - Stock Titan

Sep 17, 2026
pulisher
Sep 16, 2026

Big Phibro Animal Health (PAHC) investor lines up stock sale plan - Stock Titan

Sep 16, 2026
pulisher
Sep 09, 2026

Phibro Animal Health Corporation to Participate in Morgan Stanley Annual Global Healthcare Conference - Yahoo Finance

Sep 09, 2026
pulisher
Sep 09, 2026

Phibro Animal Health Corporation to Participate in Morgan Stanley Annual Global Healthcare Conference - Business Wire

Sep 09, 2026
pulisher
Sep 04, 2026

Phibro Animal Health (PAHC) Sets 2027 Guidance, Is The Stock Still A Bargain? - Yahoo Finance

Sep 04, 2026
pulisher
Sep 02, 2026

Phibro Animal Health Corp (PAHC) Shares Surge 3.9% -- What GF Sc - GuruFocus

Sep 02, 2026
pulisher
Sep 02, 2026

Should Value Investors Buy Phibro Animal Health (PAHC) Stock? - Yahoo Finance

Sep 02, 2026
pulisher
Sep 01, 2026

Understanding Phibro (PAHC) Reliance on International Revenue - Yahoo Finance

Sep 01, 2026
pulisher
Aug 30, 2026

Teleconferência de Resultados do 4º Trimestre Fiscal e do Ano Fiscal de 2026 da PAHC: Crescimento das Vendas, Guidance para 2027 e Risco Brasil - TradingKey

Aug 30, 2026
pulisher
Aug 30, 2026

Phibro Animal Health Corporation Class A (PAHC) Peer Comparison – Compare with Others - Value Research

Aug 30, 2026
pulisher
Aug 29, 2026

Phibro Animal Health Corporation Class A (PAHC) Key Financial Ratios – Valuation, Profitability & More - Value Research

Aug 29, 2026
pulisher
Aug 28, 2026

Phibro Animal Health Corporation Class A (PAHC) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research

Aug 28, 2026
pulisher
Aug 28, 2026

PAHC Q2 Deep Dive: Diverse Portfolio Offsets Regulatory and Margin Headwinds - Yahoo Finance

Aug 28, 2026
pulisher
Aug 27, 2026

Phibro Animal Health declares $0.12 quarterly dividend - scanx.trade

Aug 27, 2026
pulisher
Aug 27, 2026

Earnings call transcript: Phibro Animal Health tops Q4 2026 estimates - Investing.com

Aug 27, 2026
pulisher
Aug 27, 2026

Earnings call transcript: Phibro Animal Health tops Q4 2026 estimates By Investing.com - Investing.com India

Aug 27, 2026
pulisher
Aug 27, 2026

Phibro Q4 FY26 slides: record year, margins expand on Zoetis deal - investing.com

Aug 27, 2026
pulisher
Aug 27, 2026

PAHC SWOT Analysis: Strong Growth Potential Amidst Valuation Con - GuruFocus

Aug 27, 2026
pulisher
Aug 26, 2026

Is Phibro Animal Health Corp (PAHC) Overvalued After Q4 Earnings - GuruFocus

Aug 26, 2026
pulisher
Aug 26, 2026

Phibro Animal Health Corp reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 26, 2026
pulisher
Aug 26, 2026

Phibro Animal Health Submits Annual 10-K Report for Fiscal Year Ending June 30, 2026 - Kalkine Media

Aug 26, 2026
pulisher
Aug 26, 2026

(PAHC) Phibro Animal Health Expects Fiscal 2027 Revenue Range $1.55B$1.60B, vs. FactSet Est of $1.55B - marketscreener.com

Aug 26, 2026
pulisher
Aug 26, 2026

Earnings Flash (PAHC) Phibro Animal Health Posts Fiscal Q4 Revenue $396.7M, vs. FactSet Est of $381.2M - marketscreener.com

Aug 26, 2026
pulisher
Aug 26, 2026

Phibro Animal Health Corporation (PAHC) Stock Rises on Q4 2026 Earnings - Quiver Quantitative

Aug 26, 2026
pulisher
Aug 26, 2026

Phibro Animal Health jumps 5% on strong Q4 earnings and guidance beat - Investing.com

Aug 26, 2026
pulisher
Aug 26, 2026

PHIBRO ANIMAL HEALTH CORP FY 2026: Revenue $1.52B, EPS $2.43— 10-K Summary - TradingView

Aug 26, 2026
pulisher
Aug 26, 2026

Phibro: Fiscal Q4 Earnings Snapshot - KVUE

Aug 26, 2026
pulisher
Aug 26, 2026

Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year Results, Provides Financial Guidance - Yahoo Finance

Aug 26, 2026
pulisher
Aug 26, 2026

Phibro Animal Health sets FY27 adj EPS $3.41-$3.59, beats est - scanx.trade

Aug 26, 2026
pulisher
Aug 26, 2026

Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year Results, Provides Financial Guidance - Business Wire

Aug 26, 2026
pulisher
Aug 25, 2026

JPMorgan reiterates Phibro Animal Health stock rating on solid outlook By Investing.com - Investing.com Nigeria

Aug 25, 2026
pulisher
Aug 25, 2026

JPMorgan reiterates Phibro Animal Health stock rating on solid outlook By Investing.com - Investing.com Canada

Aug 25, 2026
pulisher
Aug 25, 2026

JPMorgan reiterates Phibro Animal Health stock rating on solid outlook By Investing.com - Investing.com India

Aug 25, 2026
pulisher
Aug 25, 2026

Earnings To Watch: Phibro Animal Health (PAHC) Reports Q2 Results Tomorrow - Yahoo Finance

Aug 25, 2026
pulisher
Aug 21, 2026

Phibro Animal Health Corp (PAHC) Shares Surge 3.2% -- What GF Sc - GuruFocus

Aug 21, 2026

Phibro Animal Health Corp (PAHC) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Phibro Animal Health Corp (PAHC) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Weinstein Judith
Officer
Aug 04 '26
Proposed Sale
36.60
472
17,275
0
Bendheim Daniel M
Officer
Aug 04 '26
Proposed Sale
36.60
486
17,787
0
Escudero Lisa Ann
Officer
Aug 04 '26
Proposed Sale
36.60
265
9,699
0
David Glenn
Officer
Aug 04 '26
Proposed Sale
36.60
840
30,744
0
BENDHEIM JACK
Officer
Aug 04 '26
Proposed Sale
36.60
2,303
84,288
0
Miller Larry Lee
Officer
Aug 04 '26
Proposed Sale
36.60
635
23,241
0
BFI Co. LLC
10% Owner
Jun 16 '26
Proposed Sale
31.87
281,600
8,974,592
0
CORCORAN E THOMAS
Director
May 29 '26
Buy
31.77
10,000
317,700
41,459
BENDHEIM JACK
President and CEO
May 07 '26
Sale
48.49
4,528
219,568
56,152
BENDHEIM JACK
President and CEO
May 06 '26
Sale
57.37
7,040
403,850
60,680
$72.29
price up icon 0.01%
$36.34
price up icon 0.03%
$50.31
price down icon 1.99%
$5.00
price down icon 5.84%
$10.31
price up icon 2.38%
$10.01
price down icon 2.82%
大文字化:     |  ボリューム (24 時間):